Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jan;66(1):e26-e27.
doi: 10.1097/MPG.0000000000001794.

The Case for Thoughtful Prescribing of Proton Pump Inhibitors in Infants

Rachel L Rosen  1 , Usha Krishnan  2 , Hayat Mousa  3 , Luigi Dall'oglio  4 , Christophe Faure  5 , Frederic Gottrand  6
Affiliations
Comment

The Case for Thoughtful Prescribing of Proton Pump Inhibitors in Infants

Rachel L Rosen et al. J Pediatr Gastroenterol Nutr. 2018 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest and Sources of Funding: This work was supported by the Translational Research Program at Boston Children's Hospital and R01 DK097112-01 from the National Institutes of Health. The authors have no conflicts of interest to disclose.

Comment on

References

    1. Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals. J Pediatr. 2016 - PMC - PubMed
    1. Blank ML, Parkin L. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012) J Pediatr Gastroenterol Nutr. 2017;65:179–184. - PubMed
    1. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514–520 e514. - PubMed
    1. Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143:219–223. - PubMed
    1. Krishnan U, Mousa H, Dall’Oglio L, et al. ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children With Esophageal Atresia-Tracheoesophageal Fistula. J Pediatr Gastroenterol Nutr. 2016;63:550–570. - PubMed

Substances